Background. Body weight control is considered essential for the management of diabetes mellitus. Clinicians have an important role in educating and guiding patients with diabetes to control their body weight. The aim of the present study was to clarify if clinic visits influenced body weight control of people with prediabetes or diabetes mellitus. Objective. To examine whether individuals with diabetes mellitus who visit clinics show better weight control. Method. We used a large Japanese database (Japan Medical Data Center, Tokyo, Japan) of screening for lifestyle disease linked with administrative claim data to retrospectively identify people with prediabetes or diabetes mellitus based on their fasting plasma glucose and glycated haemoglobin (HbA1c) concentration. We collected data on their baseline characteristics (including age, sex, body mass index and disease history) and their lifestyles. We used propensity-score inverse probability of treatment weighted generalized estimating equations to examine the association between clinic visits and change in body mass index. Results. Between 2013 and 2014, we identified 11 004 individuals with prediabetes or diabetes. The proportions visiting clinics after the first diagnosis made at screening was 27.8%. Clinic visit was significantly associated with lower body mass index after adjustment for baseline patient characteristics a year after first screening (−0.17 kg/m
Introduction
Weight management is a critical factor in preventing the development of type 2 diabetes mellitus (T2DM). Although the normal range of body mass index (BMI) depends on ethnic group, it is well recognized that the risk of T2DM and its complications increases as BMI increases (1) . A previous study reported that approximately 65% of the risk of T2DM can be attributed to being overweight (1) .
Losing weight also plays an important role in the management of T2DM. The Diabetes Prevention Program reported a 16% risk reduction for T2DM for every kilogram of weight loss (2) . Thus, early screening for T2DM and lifestyle modification programs, with a particular focus on weight management, are crucial. Previous studies have reported that intensive lifestyle modification (including diet, exercise and behavioural changes) was more effective than drugs for both losing weight and preventing T2DM (3) . Smoking, chronic sleep deprivation and excessive alcohol consumption also have metabolic effects and are modifiable risk factors for T2DM (1, (4) (5) (6) (7) (8) (9) .
Although several intervention programs have been effective in randomized trials, they were resource intensive, requiring regular counselling and monitoring of adherence (10) . Such interventions are often impractical in a real-world clinical setting due to limited staff time and availability; consequently, primary care physicians are generally expected to convey health education to patients with T2DM. However, it is not known whether a clinic visit is effective for body weight control of people with diabetes.
The aim of this study was to investigate the impact of primary care consultations on BMI in individuals with newly diagnosed prediabetes or diabetes mellitus, using a large database of annual health surveillance records linked with administrative claims data in Japan.
Methods

Universal lifestyle disease screening in Japan
Japan's universal healthcare coverage provides all workers with annual health check-ups. The nationwide annual screening for lifestyle diseases started in 2008 for those aged 40 or more, and focuses on metabolic syndrome (visceral fat syndrome). Individuals suspected of having lifestyle diseases at the time of screening are encouraged to visit a clinic or their primary care provider for advice on disease management. The screening program includes recording of blood pressure, anthropometric measurements, chest X-ray, electrocardiography, blood tests and completion of a self-reported health questionnaire to assess physical activity and eating behaviours (11) . The questionnaire includes the following questions on physical activity and eating behaviours, based on the National Nutrition Survey in Japan (11): (i) 'Do you walk for at least 1 hour a day?' (regular exercise, moderate); (ii) 'Have you been in the habit of regular exercise of over 30 minutes about twice a week, for more than a year?' (regular exercise, hard); (iii) 'Do you have dinner within 2 hours of bedtime, three or more times a week?' (late dinner); (iv) 'Do you eat snacks after dinner three or more times a week?' (midnight snacking); (v) 'Do you skip breakfast three or more times a week?' (skipping breakfast); and (vi) 'Is your eating speed normal, fast or slow?' (eating speed). In the present study, we defined 'eating habits' as the number of 'yes' answers given to the questions about late dinner, midnight snacks and skipping breakfast.
Frequency of alcohol consumption per week was categorized as 'rarely', 'sometimes' or 'daily'. The Japanese sake-equivalent quantity of alcohol consumed per day was categorized as <180 ml, 180-359 ml, 360-539 ml or ≥540 ml. In this study, people consuming 180 ml or more sake-equivalent alcohol daily were defined as belonging to the excess alcohol consumption group, according to guidelines published by the Ministry of Health, Labour and Welfare of Japan.
Sleep deprivation was assessed with the following question: 'Do you sleep well and enough?' Those who answered 'No' to this question were regarded as having sleep deprivation.
Data source
For this study, we used the Japan Medical Data Center (JMDC) database. The JMDC is contracted with more than 60 insurers, and collects data on annual health lifestyle disease screening records linked with health insurance claim data from approximately 1.5 million insured individuals in 2013. The original data include personal information, including name, date of birth, insurance certificate number and medical institution's name. The JMDC provides researchers with de-identified data (12) . The majority of insured individuals in the JMDC database are employees of Japanese companies. The database includes information about annual lifestyle disease screening and administrative claim data for clinic visits and hospital admissions. Diagnoses are recorded based on International Classification of Diseases, 10th revision (ICD-10) codes.
Given the de-identified nature of the data, the requirement for informed consent was waived. Conduct of the study was approved by the institutional review board of The University of Tokyo.
Data extraction
We examined the following data from the JMDC database between 2013 and 2014: age; sex; BMI at lifestyle disease screening; all drug prescriptions; diagnoses; the concentrations of glycated haemoglobin (HbA1c) and fasting plasma glucose (FPG); and all medical procedures including oral glucose tolerance test (OGTT). We then extracted data on individuals who had (i) lifestyle disease screening records for at least two consecutive years, and (ii) FPG ≥110 mg/dl or HbA1c ≥5.6% (NGSP units) (38 mmol/mol) at the first lifestyle disease screening. We excluded data on: (i) individuals who had already visited clinics for diabetes care within 6 months of the first lifestyle disease screening; (ii) those with anaemia (haemoglobin ≤12 g/dl for men and ≤11 g/dl for women); (iii) those with schizophrenia receiving drugs with the potential to affect FPG, such as aripiprazole, quetiapine, olanzapine, risperidone and clozapine; and (iv) those taking corticosteroids. We then selected individuals with prediabetes (FPG, 110-126 mg/dl and HbA1c < 6.5% (48 mmol/ mol)) and diabetes (FPG ≥126 mg/dl or HbA1c ≥6.5% (48 mmol/mol)) according to the guideline published by the Japan Diabetes Society in 2014 (as shown in Figure 1 ). Under the Japanese criterion for lifestyle disease screening, those with prediabetes are recommended to visit a clinic for further examination, and patients with diabetes are recommended to receive diabetes care at a primary care clinic.
We identified patients who received primary diabetes care after first lifestyle disease screening using the following information: prescription of an antidiabetic drug (all available oral hypoglycemic agents and insulin licensed for use in Japan); identification of a blood test for FPG and/or HbA1c, and/or an OGTT performed other than at screening. To adjust for potential effects of chronic diseases on BMI change and on individuals' care-seeking behaviour, we used prescription information and ICD-10 codes to identify those with hypertension, dyslipidemia, asthma, cardiovascular disease, cerebrovascular disease, mental disorder, liver disease, chronic obstructive pulmonary disease, neurologic disease or cancer. We defined 'chronic disease' as one or more of these comorbid conditions.
Data analysis
We compared baseline characteristics between the two groups using standardized differences. To minimize potential confounding by indication (i.e. patients with clinic visit may have had worse outcomes than those without clinic visit simply because they were more unwell), we applied inverse probability of treatment (IPT) weighting using propensity scores to balance baseline characteristics between the groups. In this method, patients who visited clinics were weighted for the reciprocal of the propensity score, and those who did not were weighted for the reciprocal of 1 minus the propensity score. To create propensity scores, a logistic regression model was used with clinic visit as the dependent variable and age, sex, chronic diseases, smoking status (ex-or current smoking, no smoking), excessive alcohol consumption, exercise (moderate only, hard only, both moderate and hard), eating habits (the number of 'yes' responses to late dinner, midnight snacks, skipping breakfast; 1 to 3), eating speed (normal, fast, slow), any subjective symptoms of chronic disease (yes, no; doctors decide whether the symptoms are related to chronic disease), and intent to see a health adviser (e.g. physician, public health nurse, registered dietitian) for guidance on lifestyle change (yes, no), included as independent variables. These variables were selected according to previous publications (4-9,13). For univariate comparisons, we used Student's t-test to compare the averages of lifestyle disease screening intervals, and the Wilcoxon rank sum test to compare BMI change between the groups with and without clinic visits. For the IPTweighted group, we applied generalized estimating equations (GEE) to test the relationship between clinic visit and BMI change by including the interaction between the clinic visit and screening variables (first or second screening). The significance of this interaction term represents the size of the effect of clinic visit on BMI change in isolation from spontaneous BMI change over time. For a subgroup analysis of GEE, we included only those without prescriptions for diabetes at the subsequent clinic visit, to remove the influence of antidiabetic drugs on weight change. We repeated the same analyses including only those who met the diabetes criteria. For sensitivity analyses, we stabilized and trimmed the IPT weights to restrict the influence of outlier weights. The weights were set to 0.10 if the stabilized weight was less than 0.10, and to 10 if the stabilized weight was greater than 10 (14). All statistical analyses were two-tailed and P values <0.05 were considered significant. All statistical computations were performed with SPSS version 22 (IBM SPSS, Armonk, NY).
Results
We identified 107 528 individuals with FPG ≥110 mg/dl or HbA1c ≥5.6% (38 mmol/mol) at the first lifestyle disease screening in the database. We excluded 7117 individuals with missing data in the 6 months before the first lifestyle disease screening, 11 940 who had already received diabetes care within 6 months of the first screening, 3625 with anaemia, 542 using one or more of the antipsychotic drugs listed above, and 20 242 taking corticosteroids. Of the remaining 64 062 individuals, we identified 11 004 with prediabetes or diabetes based on the criteria of the Japan Diabetes Society (Figure 1) .
The proportion of patients who visited clinics after the first screening was 27.8%. Table 1 shows patient demographics and clinical characteristics unadjusted and adjusted by IPT weights for individuals with and without clinic visits. The two groups were balanced for all included variables (all standardized differences were less than 0.1). After applying IPT weighting, the mean (SD) BMI at baseline was 24.9 (4.1) kg/m 2 for patients without clinic visits and 24.7 (4.0) kg/m 2 for those with clinic visits (standardized difference = 0.030). In the IPT weighted cohort, 28% of individuals with clinic visits were prescribed antidiabetic drugs. Table 2 shows the results of the univariate analysis of BMI at the second lifestyle disease screening between the two groups. The mean (SD) interval of two lifestyle disease screenings was 11.8 ( The results of the IPT weighted GEE showed that BMI at the second clinic visit was significantly lower than that of individuals without clinic visits (−0.17 kg/m 2 ; 95% confidence interval, −0.22 to −0.12; P < 0.001) ( Table 3) .
Another IPT-weighted GEE that excluded individuals taking antidiabetic drugs showed greater reduction of BMI in those with clinic visits (−0.18 kg/m 2 ; 95% confidence interval, −0.24 to −0.12; P < 0.001) ( Table 4) . Results were similar from analyses that included only those individuals with diabetes ( Supplementary Tables 1 and 2 ). The results were also similar for all sensitivity analyses.
Discussion
Despite screening results and consequent recommendations to visit clinics, the proportion of individuals who visited clinics was less than 30% in the present study. We found a significant association between subsequent clinic visits after first screening and reduction in BMI in patients newly diagnosed with prediabetes or diabetes, even after adjusting for multiple confounding factors. Data are presented as the mean (standard deviation) for continuous variables. Categorical variables are reported as a number, n (proportion, %) for the unadjusted groups, and proportion % for the inverse probability of treatment-weighted groups. Eating habit represents the number of 'yes' answers given to the questions about late dinner, midnight snacks and skipping breakfast.
BMI, body mass index; HbA1c, glycated haemoglobin.
weight loss of approximately 0.5 kg for an individual with a height of 170 cm. These results are broadly comparable with those of previous intervention studies. A systematic review reported effectiveness of work-based intervention programs as preventing weight gain of more than 0.5 kg over 12 months (15) . Our findings indicate that clinic visits may contribute to the prevention of T2DM through better weight control when implementation of intervention programs is difficult. There are several possible explanations for the better weight control of individuals with clinic visits in the present study. First, primary care physicians had the opportunity to provide diabetes or prediabetes patients with adequate health instruction for weight management through lifestyle changes. A previous study demonstrated intensive lifestyle modifications involving diet, exercise and behaviour were more effective than drugs for weight loss (3). Another study showed an association between effective physician-patient communication and improved health outcomes (16, 17) . Primary care consultations may thus have played the same role as intervention programs for promoting lifestyle modifications. Another explanation is that patients who subsequently visited clinics were better motivated or had higher health literacy; those able to control their body weight may be more likely to seek diabetic care. In this scenario, the change in body weight may not have been a result of clinic visit.
Despite the importance of primary care and the recommendations made following lifestyle disease screening, more than 70% of individuals with diabetes did not seek primary care. A previous study reported that in the USA, having health insurance affected affordability of primary care (18) . This does not apply to our study, because Japan has a universal healthcare system. We believe the most likely explanations for the low number of clinic visits in this study were lack of awareness of the health implications of diabetes and difficulty in taking time off work for clinic visits (19) (20) (21) .
A strength of our study was the large number of patients, both at baseline and at follow-up. Also, medical claim data and information about drug prescription were available to validate comorbidities and treatments. However, several limitations should be acknowledged. First, the generalizability of the results may be limited because the study population was not representative of the Japanese population as a whole. This is because most patients in our study were healthy male workers aged 40-65 years and we only investigated those who attended their routine annual lifestyle disease screenings. Thus, our results may not be applicable to people who are not able to work because of illness. Second, we obtained data from two time points only, approximately a year apart, and were unable to assess longterm effects of clinic visits on BMI change. In addition, we set the baseline period at 6 months for identification of individuals who had already been treated for diabetes. This may have been too short to identify all potential T2DM patients. Third, we were not able to adjust for some potential confounding factors such as education level, occupation, socioeconomic status and regional variations, as these were not recorded in either of the databases. Finally, we were not able to obtain information on what and how instructions for weight management were conveyed by primary care physicians to patients.
Conclusions
In conclusion, we found that a clinic visit after diagnosis of prediabetes or diabetes was significantly associated with lower BMI, even after adjusting for patient backgrounds and lifestyles.
Nevertheless, the proportion of clinic visits was low, suggesting that many of the patients were not aware of the serious consequences of untreated diabetes. Our findings underline the importance of clinic follow-up for those found to have prediabetes or diabetes at screening.
